Preclinical testing of a novel PD-L1 inhibitor for the treatment of renal cell carcinoma.
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2024.42.4_suppl.458
Abstract: 458 Background: Immune checkpoint inhibitors (ICI) targeting PD-1/PD-L1 axis has revolutionized the therapeutic landscape of patients with advanced and locally advanced renal cell carcinoma (RCC). However, complete response rates remain low and there is a… read more here.
Keywords: inhibitor treatment; cell; h1a; cell carcinoma ... See more keywords